Click Here for 5% Off Your First Aladdin Purchase!

FASUDIL - ≥98% (HPLC), high purity , Rho-associated protein kinase inhibitor, CAS No.103745-39-7, Rho-associated protein kinase inhibitor

  • Moligand™
  • ≥98%(HPLC)
Item Number
F134784
Grouped product items
SKUSizeAvailabilityPrice Qty
F134784-250mg
250mg
In stock
$15.90
F134784-1g
1g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$41.90
F134784-5g
5g
In stock
$162.90

ROCK2 inhibitor

Basic Description

SynonymsFasudil|103745-39-7|ha-1077|HA 1077|AT 877|HA1077|Fasudil [INN]|Fasudilum|1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)-|AT-877|1-(5-Isoquinolinesulfonyl)homopiperazine|5-(1,4-diazepan-1-ylsulfonyl)isoquinoline|5-(1,4-diazepane-1-sulfonyl)isoqui
Specifications & Purity≥98%(HPLC)
Storage TempStore at -20°C
Shipped InDry ice
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionRho-associated protein kinase inhibitor

Product Properties

ALogP1

Associated Targets

CYP2D6 Tclin Cytochrome P450 2D6 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ROCK2 Tclin Rho-associated protein kinase 2 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ROCK1 Tclin Rho-associated protein kinase 1 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 5-(1,4-diazepan-1-ylsulfonyl)isoquinoline
INCHI InChI=1S/C14H17N3O2S/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14/h1,3-5,7,11,15H,2,6,8-10H2
InChi Key NGOGFTYYXHNFQH-UHFFFAOYSA-N
Canonical SMILES C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3
Isomeric SMILES C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3
PubChem CID 3547
Molecular Weight 291.37

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

7 results found

Lot NumberCertificate TypeDateItem
E2422096Certificate of AnalysisMay 11, 2024 F134784
H2206724Certificate of AnalysisMay 11, 2024 F134784
H2206584Certificate of AnalysisMay 09, 2024 F134784
B2429020Certificate of AnalysisJun 15, 2022 F134784
H2206723Certificate of AnalysisJun 15, 2022 F134784
H2303098Certificate of AnalysisJun 15, 2022 F134784
L2307083Certificate of AnalysisJun 15, 2022 F134784

Chemical and Physical Properties

SolubilitySoluble in DMSO

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

Related Documents

References

1. Huentelman MJ, Stephan DA, Talboom J, Corneveaux JJ, Reiman DM, Gerber JD, Barnes CA, Alexander GE, Reiman EM, Bimonte-Nelson HA.  (2009)  Peripheral delivery of a ROCK inhibitor improves learning and working memory..  Behav Neurosci,  123  (1): (218-23).  [PMID:19170447]
2. Doggrell SA.  (2005)  Rho-kinase inhibitors show promise in pulmonary hypertension..  Expert Opin Investig Drugs,  14  (9): (1157-9).  [PMID:16144499]
3. Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, Suzuki Y, Hidaka H.  (1989)  Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase..  Br J Pharmacol,  98  (4): (1091-100).  [PMID:2611484]
4. Shibuya M, Suzuki Y.  (1993)  [Treatment of cerebral vasospasm by a protein kinase inhibitor AT 877]..  No To Shinkei,  45  (9): (819-24).  [PMID:8217408]

Solution Calculators